Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
NeuroSense Therapeutics Ltd. NRSN
$1.69
-$0.07 (-3.98%)
На 18:05, 12 мая 2023
Ключевые показатели
-
Marketcap
20296000.00000000
-
week52high
4.47
-
week52low
1.08
-
Revenue
0
-
P/E TTM
-2
-
Beta
0.00000000
-
EPS
-0.86000000
-
Last Dividend
0.00000000
-
Next Earnings Date
22 мар 2023 г. в 14:05
Описание компании
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. Its lead product is PrimeC, an extended-release oral formulation of a fixed dose combination of ciprofloxacin and celecoxib for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
3 Ways to Make Money With Penny Stocks Right Now
PennyStocks
20 янв 2023 г. в 06:00
Use these tips for making money with penny stocks right now The post 3 Ways to Make Money With Penny Stocks Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Is NeuroSense (NRSN) Stock Up 98% Today?
InvestorPlace
19 янв 2023 г. в 11:28
NeuroSense (NASDAQ: NRSN ) stock is taking off on Thursday as investors react to data from a biomarker study concerning Alzheimer's disease ( AD ). The clinical trial covers the use of NeuroSense's combination platform therapy for the treatment of AD.
NeuroSense Therapeutics to Present at Upcoming Leading Neuroscience Conferences
PRNewsWire
27 окт 2022 г. в 08:50
CAMBRIDGE, Mass. , Oct. 27, 2022 /PRNewswire/ -- NeuroSense Therapeutics Ltd.
4 Alzheimer's Penny Stocks To Watch After Biogen Stock Explodes
PennyStocks
28 сент 2022 г. в 10:56
Penny stocks to buy [or avoid] after Biogen Alzheimer's news. The post 4 Alzheimer's Penny Stocks To Watch After Biogen Stock Explodes appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
NeuroSense Therapeutics to Present at Upcoming U.S. and European ALS Conferences
PRNewsWire
21 сент 2022 г. в 08:51
Biomarker data to be presented provide indication of PrimeC's efficacy in ALS Phase IIb PARADIGM ALS trial's primary endpoints include biomarkers and ALS-related hallmarks Topline results expected H1 2023 CAMBRIDGE, Mass. , Sept. 21, 2022 /PRNewswire/ -- NeuroSense Therapeutics Ltd.